Remote Sputum Collection in Cystic Fibrosis
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT06950892
- Status
- Recruiting
Conditions
- Cystic Fibrosis
- Infections
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections has become more challenging due to the decrease in sputum and rise of telehealth services. While the option of collecting sputum samples at home and sending them by mail may be feasible, uncertainty remains about how the collection of samples outside of clinic and delays in testing while in the mail impact infection detection. This study will compare bacterial cultures using sputum samples collected at home versus samples collected in clinic (saline-induced sputum and throat swab). This study seeks to shed light on how valuable home collected samples can be and help us better understand the usefulness of home-collected sputum samples for both clinical and research purposes.
Key Dates
- Start date
- Jan 15, 2025
- Status verified
- Sep 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Adults with cystic fibrosisPeople with cystic fibrosis age 18 years or older without a history of solid organ transplantation.
Primary Outcome Measure
Pseudomonas aeruginosa positive culture [ Time Frame: at baseline ]
Central Contacts
- Krista Ludwig267-283-6223
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Jewish Health | Denver | Colorado | 80206 | Milene Saveedra, MD (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins University | Baltimore | Maryland | 21287 | Noah Lechtzin, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Krista Ludwig 267-283-6223 Gina Hong, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Denver, CO
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Natural History of BronchiectasisRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- A Phase I Study of Mozobil in the Treatment of Patients With WHIMSPHASE1/PHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland